-+ 0.00%
-+ 0.00%
-+ 0.00%

*Aardvark Therapeutics Believe Existing Cash, Equivalents and Short-Term Investments Sufficient to Fund Projected Ops Into 2Q 2027 >AARD

Dow Jones·03/23/2026 20:10:00

Please log in to view news